Specialty Pharmacy

David G. Miller, RPh, executive vice president and CEO of the International Academy of Compounding Pharmacists, debunks what he thinks are the 3 biggest compounding pharmacy myths.

Study evaluates how antiretroviral therapy effects gut microbiota.

Average period to disease recurrence same as with placebo.

Owners prohibited from manufacturing, holding, or distributing sterile drugs until they comply with the Federal Food, Drug, and Cosmetic Act.

Economic variables impact breast cancer treatment, study finds.

Repair rate of intestinal lining dependent on interactions within the gut.

The FDA today approved the first available treatment option for patients with high-risk neuroblastoma.

The FDA has granted priority review to investigational cobimetinib in combination with vemurafenib (Zelboraf) in advanced melanoma.

Michael R. Hess, attorney with Bass Berry & Sims and outside general counsel to many of the largest independent specialty pharmacy companies, discusses streamlining contractual relationships between specialty stakeholders and drug manufacturers.

Supplemental oxygenation may shrink tumors and enhance cancer immunotherapy.

Taste pathway changes in patients on chemotherapy for basal cell carcinoma.

Patients found to less antioxidant and anti-inflammatory nutrients.

Study argues for more balanced information for patients before making a treatment decision.

Biosimilars are finally a reality in the US drug market, but a report warns regulatory decisions may limit future savings from the drugs.

After years of debate and regulatory hurdles, a milestone was achieved today when the FDA approved the first biosimilar in the United States.

Study identifies drug candidates to promote differentiation and myelin production.

Patients receiving chemotherapy after surgery had a 30% lower risk of death than those who had surgery alone.

Medication adherence, hospital readmissions, and surgical complications have significant differences related to race.

Researchers report results of a novel silk protein to help make pharmaceuticals less susceptible to heat-related product loss, highlighting the importance of proper cold chain conditions.

The FDA announced today that it has expanded the indication of Bristol-Myers Squibb's anticancer medication nivolumab (Opdivo) to include the treatment of patients with metastatic squamous non-small cell lung cancer with progression on or after platinum-based chemotherapy.

Worried about potential drug shortages? There's an app for that.

Better chemotherapy drugs lead to increased usage prior to breast operations over last 5 years.

Study examines link between caffeine intake and reduced symptoms of multiple sclerosis.

Interferon-free, all-oral drug regimens result in high rates of sustained virologic response for patients co-infected with hepatitis C virus and HIV.

Raulo Frear, PharmD, general manager of OmedaRx, discusses developing trends in medication compliance.

Mortality rates also affected by age and poor nutrition.

Expanded use would include treatment of patients with advanced squamous non-small cell lung cancer who received prior therapy.

Compound can monitor biochemical processes involved with protein kinases.

Many physicians still use technique that fails to detect deep tissue lesions near the chest wall.